A pharmacogenetic study of response to a 5-lipoxygenase inhibitor in a Phase II clinical trial.

被引：0
|
作者：
Lewitzky, S
Barnes, G
Garg, P
Metivier, J
Chang, M
Rosengren, B
Meyer, J
机构：
[1] Millennium Pharmaceut Inc, Dept Clin Dev, Cambridge, MA USA
[2] Millennium Pharmaceut Inc, Dept Mol & Cellular Pharmacol, Cambridge, MA USA
[3] Millennium Pharmaceut Inc, Dept Mol Epidemiol, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2003年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1288
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies
    Marr, K
    Marsh, K
    Hernandez, L
    Cunningham, FM
    Lees, P
    RESEARCH IN VETERINARY SCIENCE, 1998, 64 (02) : 111 - 117
  • [22] ZILEUTON - A 5-LIPOXYGENASE INHIBITOR IN RHEUMATOID-ARTHRITIS
    WEINBLATT, ME
    KREMER, JM
    COBLYN, JS
    HELFGOTT, S
    MAIER, AL
    PETRILLO, G
    HENSON, B
    RUBIN, P
    SPERLING, R
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (10) : 1537 - 1541
  • [23] Synthesis and Structural Proof of a Potent 5-Lipoxygenase Inhibitor
    Balu, Devipriya
    Poomani, Kumaradhas
    Nagabushanam, Kalyanam
    Balasubramanium, Sridhar
    Ramanujam, Rajendran
    Muhammed, Majeed
    JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, 2011, 41 (05) : 697 - 702
  • [24] Synthesis and Structural Proof of a Potent 5-Lipoxygenase Inhibitor
    Devipriya Balu
    Kumaradhas Poomani
    Kalyanam Nagabushanam
    Sridhar Balasubramanium
    Rajendran Ramanujam
    Majeed Muhammed
    Journal of Chemical Crystallography, 2011, 41 : 697 - 702
  • [25] The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor
    Ducharme, Yves
    Blouin, Marc
    Brideau, Christine
    Chateauneuf, Anne
    Gareau, Yves
    Grimm, Erich L.
    Juteau, Helene
    Laliberte, Sebastien
    MacKay, Bruce
    Masse, Frederic
    Ouellet, Marc
    Salem, Myriam
    Styhler, Angela
    Friesen, Richard W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (04): : 170 - 174
  • [26] TOPICAL TREATMENT OF PSORIASIS WITH A SELECTIVE 5-LIPOXYGENASE INHIBITOR
    JANSEN, CT
    LAMMINTAUSTA, K
    BULLINGHAM, RES
    FORSSTROM, S
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (02) : 154 - 154
  • [27] EFFECT OF 5-LIPOXYGENASE INHIBITOR ON CANINE PANCREATIC ALLOTRANSPLANTATION
    HORICHI, H
    IZUMI, R
    SHIMIZU, K
    KONISHI, K
    KITABAYASHI, K
    WATANABE, T
    MIYAZAKI, I
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1679 - 1680
  • [28] Treatment of inflammatory acne with an oral 5-lipoxygenase inhibitor
    Zouboulis, C
    Nestoris, S
    Adler, Y
    Picardo, M
    Camera, E
    Orth, M
    Orfanos, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 547 - 547
  • [29] Zileuton: The first 5-lipoxygenase inhibitor for the treatment of asthma
    Wenzel, SE
    Kamada, AK
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (7-8) : 858 - 864
  • [30] SYNTHESIS OF THE 5-LIPOXYGENASE INHIBITOR ZILEUTON FROM THIOPHENOL
    BASHA, A
    BROOKS, DW
    JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (05): : 1293 - 1294
12345